Controversies in papillary microcarcinoma of the thyroid
- PMID: 14586064
- DOI: 10.1007/s12022-003-0011-5
Controversies in papillary microcarcinoma of the thyroid
Abstract
Papillary thyroid carcinomas that are smaller than 1 cm are classified as papillary microcarcinomas (PMC). These lesions are frequently detected as incidental findings on autopsy or in surgical specimens. They are often multifocal. The relationship between PMC and clinical papillary thyroid carcinoma (PTC) is not clear. In patients with clinical thyroid cancer, PMC may represent intrathyroidal metastases; they may be the earliest form of future large lesions. These uncertainties raise questions about appropriate clinical management of patients with these lesions. Review of the literature substantiates the argument that clinically evident PTC may be distinctly different from solitary or multifocal PMC in terms of etiology and biologic behavior, supporting a conservative approach to management.
Similar articles
-
Treatment for microcarcinoma of the thyroid--clinical experience.Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d. Clin Nucl Med. 2007. PMID: 17413573
-
Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series.Endocr Pathol. 2006 Summer;17(2):165-73. doi: 10.1385/ep:17:2:165. Endocr Pathol. 2006. PMID: 17159249
-
Prognostic factors in papillary microcarcinoma with emphasis on histologic subtyping: a clinicopathologic study of 148 cases.Thyroid. 2014 Feb;24(2):245-53. doi: 10.1089/thy.2012.0645. Epub 2013 Sep 4. Thyroid. 2014. PMID: 23745671
-
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.Eur J Surg Oncol. 2018 Mar;44(3):307-315. doi: 10.1016/j.ejso.2017.03.004. Epub 2017 Mar 16. Eur J Surg Oncol. 2018. PMID: 28343733 Review.
-
[Thyroid microcarcinoma].Arkh Patol. 2006 Jul-Aug;68(4):54-7. Arkh Patol. 2006. PMID: 16986502 Review. Russian.
Cited by
-
A missense polymorphism (rs11895564, Ala380Thr) of integrin alpha 6 is associated with the development and progression of papillary thyroid carcinoma in Korean population.J Korean Surg Soc. 2011 Nov;81(5):308-15. doi: 10.4174/jkss.2011.81.5.308. Epub 2011 Nov 1. J Korean Surg Soc. 2011. PMID: 22148122 Free PMC article.
-
Multifocal papillary thyroid carcinoma--a consensus report of the European Society of Endocrine Surgeons (ESES).Langenbecks Arch Surg. 2014 Feb;399(2):141-54. doi: 10.1007/s00423-013-1145-7. Epub 2013 Nov 22. Langenbecks Arch Surg. 2014. PMID: 24263684 Review.
-
Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors.World J Surg. 2009 Mar;33(3):460-8. doi: 10.1007/s00268-008-9870-8. World J Surg. 2009. PMID: 19123022
-
c-Met inhibitor synergizes with tumor necrosis factor-related apoptosis-induced ligand to induce papillary thyroid carcinoma cell death.Mol Med. 2012 Mar 27;18(1):167-77. doi: 10.2119/molmed.2011.00238. Mol Med. 2012. PMID: 22113498 Free PMC article.
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis.Am J Hum Genet. 2016 Jun 2;98(6):1170-1180. doi: 10.1016/j.ajhg.2016.04.014. Epub 2016 May 26. Am J Hum Genet. 2016. PMID: 27236916 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical